Literature DB >> 18679772

Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Ram K Balachandran1, Victor H Barocas.   

Abstract

PURPOSE: The direct penetration route following transscleral drug administration presents several barrier and clearance mechanisms-including loss to choroidal blood flow, active transport by the retinal pigment epithelium (RPE), and loss to the conjunctival lymphatics and episcleral blood vessels. The objective of this research was to quantify the role of choroidal and episcleral losses.
MATERIALS AND METHODS: A finite element model was created for drug distribution in the posterior human eye. The volumetric choroidal loss constant, active transport component and mass transfer from the scleral surface were unknown parameters in the model. The model was used to simulate drug distribution from a systemic source, and the results were compared to existing experimental results to obtain values for the parameters.
RESULTS: The volumetric choroidal loss constant, mass transfer coefficient from the scleral surface and active transport component were evaluated to be (2.0 +/- 0.6) x 10(-5) s(-1), (2.0 +/- 0.35) x 10(-5) cm/s and 8.54 x 10(-6) cm/s respectively.
CONCLUSION: Loss to the choroidal circulation was small compared to loss from the scleral surface. Active transport was predicted to induce periscleral movement of the drug, resulting in more rapid distribution and elevated drug concentrations in the choroid and sclera.

Entities:  

Mesh:

Year:  2008        PMID: 18679772     DOI: 10.1007/s11095-008-9691-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  61 in total

Review 1.  Drug delivery for posterior segment eye disease.

Authors:  D H Geroski; H F Edelhauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

Review 2.  Drug delivery to the posterior segment from drops.

Authors:  David M Maurice
Journal:  Surv Ophthalmol       Date:  2002-08       Impact factor: 6.048

3.  Fitting numerical solutions of differential equations to experimental data: a case study and some general remarks.

Authors:  P Dalgaard; M Larsen
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

4.  Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume.

Authors:  S Friedrich; Y L Cheng; B Saville
Journal:  Curr Eye Res       Date:  1997-07       Impact factor: 2.424

5.  Measurement of the volume flow and hydraulic conductivity across the isolated dog retinal pigment epithelium.

Authors:  S Tsuboi
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-11       Impact factor: 4.799

6.  Capillary permeability to and extravascular dynamics of myoglobin, albumin and gammaglobulin in the uvea.

Authors:  A Bill
Journal:  Acta Physiol Scand       Date:  1968 May-Jun

7.  Diffusion across the sclera.

Authors:  D M Maurice; J Polgar
Journal:  Exp Eye Res       Date:  1977-12       Impact factor: 3.467

8.  Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration.

Authors:  Surya P Ayalasomayajula; Uday B Kompella
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

9.  In vivo transscleral iontophoresis of amikacin to rabbit eyes.

Authors:  David L Vollmer; Margaret A Szlek; Kenneth Kolb; Lindsay B Lloyd; Thomas M Parkinson
Journal:  J Ocul Pharmacol Ther       Date:  2002-12       Impact factor: 2.671

10.  Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.

Authors:  N P Blair; M A Evans; T S Lesar; R C Zeimer
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-07       Impact factor: 4.799

View more
  13 in total

1.  Extended Pharmacokinetic Model of the Rabbit Eye for Intravitreal and Intracameral Injections of Macromolecules: Quantitative Analysis of Anterior and Posterior Elimination Pathways.

Authors:  Marko Lamminsalo; Ella Taskinen; Timo Karvinen; Astrid Subrizi; Lasse Murtomäki; Arto Urtti; Veli-Pekka Ranta
Journal:  Pharm Res       Date:  2018-05-31       Impact factor: 4.200

2.  Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment.

Authors:  Nahid Haghjou; Mohammad J Abdekhodaie; Yu-Ling Cheng
Journal:  Pharm Res       Date:  2012-10-02       Impact factor: 4.200

3.  Prediction of passive drug permeability across the blood-retinal barrier.

Authors:  Aapo Tervonen; Iina Vainio; Soile Nymark; Jari Hyttinen
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

4.  Contribution of saccadic motion to intravitreal drug transport: theoretical analysis.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2011-01-22       Impact factor: 4.200

5.  Whole vitreous humor dissection for vitreodynamic analysis.

Authors:  Karthik Murali; Amir H Kashani; Mark S Humayun
Journal:  J Vis Exp       Date:  2015-05-24       Impact factor: 1.355

Review 6.  Ocular Fluid Mechanics and Drug Delivery: A Review of Mathematical and Computational Models.

Authors:  Ajay Bhandari
Journal:  Pharm Res       Date:  2021-12-22       Impact factor: 4.200

Review 7.  Diffusive Transport in the Vitreous Humor: Experimental and Analytical Studies.

Authors:  Anita Penkova; Rex Moats; Mark S Humayun; Scott Fraser; Satwindar Singh Sadhal
Journal:  J Heat Transfer       Date:  2019-04-01       Impact factor: 1.855

8.  Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat.

Authors:  Jessica E Chan; Tiffany A Pridgen; Karl G Csaky
Journal:  Exp Eye Res       Date:  2010-01-11       Impact factor: 3.467

9.  Estimating outflow facility through pressure dependent pathways of the human eye.

Authors:  David W Smith; Bruce S Gardiner
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

10.  Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.

Authors:  Yu Zhang; Hojjat Bazzazi; Raquel Lima E Silva; Niranjan B Pandey; Jordan J Green; Peter A Campochiaro; Aleksander S Popel
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.